Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator announces second round of awards

(Alzheimer's Drug Discovery Foundation) The Alzheimer's Drug Discovery Foundation (ADDF) announced 6 new investments totaling $6 million through its Diagnostics Accelerator initiative. These current awards include research for blood tests in various stages of development, with one close to becoming a viable diagnostic tool for early detection of Alzheimer's disease. Other research efforts include the development of ocular and genetic tests that will aid in diagnosis and appropriate clinical trial design for intervention and disease monitoring for Alzheimer's disease and related dementias.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news